Implant Sciences Extends Global Distribution Network Into Switzerland
Expanding both its global reach and sales of its new QS-B220 system, Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced that it has added a new distributor in Switzerland. This is the Company’s first distributor in that country. The new distributor has purchased a Quantum Sniffer™ QS-B220 system to use as a demonstration unit.
The QS-B220 is a desktop explosives and drugs trace detector that is currently being evaluated for certification by the U.S. Transportation Security Administration (TSA) for air cargo screening. Introduced last year, the system is already deployed in Europe, the Middle East, Asia, and the Americas.
“The QS-B220’s ease of use, ability to clear rapidly after detection, and large color touch-screen are receiving growing attention from security professionals worldwide. Furthermore, in a world increasingly concerned about radiation safety, Implant Sciences’ non-radioactive design is subject to far fewer regulations and restrictions than competing systems,” stated Implant Sciences’ Vice President of Global Sales and Marketing, Dr. Darryl Jones. “We see a bright future for the QS-B220, one that will only get brighter as we secure certifications from government regulatory agencies around the world.”
About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive and narcotics trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences’ QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and the Company’s QS-B220 desktop explosives and drugs trace detector has received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company’s website at www.implantsciences.com.

